Dr. Petros Grivas Shares the Practice Changing Studies From ASCO GU 2023
By Oncology Brothers - February 22, 2023Petros Grivas, MD, PhD, Clinical Director of the Genitourinary Cancer Program and a Professor in the Division of Medical Oncology at Fred Hutch Cancer Center, highlights the practice-changing and informing studies that have come out of the ASCO GU 2023 Symposium – including TALAPRO-2, TRITON3, CheckMate 274, and COSMIC-313, among others.
Related Posts
Neeraj Agarwal, MD, shares the standard-of-care treatment algorithms for localized prostate cancer, CSPC, and CRPC.
Elizabeth Plimack, MD, MS, Deputy Director, Fox Chase Cancer Center, shares her approach to treating renal cell cancer.
Andrea Apolo, MD, Chief of Bladder Cancer - Genitourinary Malignancy at the NCI, discusses bladder cancer treatment.
670 Madison Ave.
Manalapan, NJ 07726